Advanced Medical Isotope Corporation to Present at United Pharmacy Partners 2008 Annual Meeting.CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. to Discuss the Company's Solutions to the Impending im·pend intr.v. im·pend·ed, im·pend·ing, im·pends 1. To be about to occur: Her retirement is impending. 2. U.S. Medical Isotope Supply Shortage Friday, September 26, 2008, Orlando, Florida KENNEWICK, Wash. -- Advanced Medical Isotope Corporation ("AMIC Am´ic a. 1. (Chem.) Related to, or derived, ammonia; - used chiefly as a suffix; as, amic acid; phosphamic acid. s> Amic acid (Chem. ") (OTHER OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). : ADMD (ADministrative Management Domain) A public e-mail service. See X.400. ADMD - Administration Management Domain , http://www.isotopeworld.com), a company engaged in the production and distribution of medical isotopes, has accepted an invitation to present at the United Pharmacy Partners, Inc.'s (UPPI UPPI University of the Philippines Population Institute UPPI United Pharmacy Partners, Inc. ) 2008 Annual Meeting. The event will be held September 24-27, 2008 at Disney's Contemporary Resort Disney's Contemporary Resort is located at Walt Disney World Resort near Orlando, Florida. It is owned and operated by The Walt Disney Company, first opened October 1, 1971, at which time it featured state-of-the-art facilities. Walt Disney World Noun 1. Walt Disney World - a large amusement park established in 1971 to the southwest of Orlando Orlando - a city in central Florida; site of Walt Disney World ([R]) in Orlando, Florida. James C. Katzaroff, AMIC's chief executive, will give a presentation entitled, "AMIC: Solution to Impending U.S. Isotope Supply Shortage," at 8:00 AM EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT on Friday, September 26, 2008. During his presentation, Mr. Katzaroff will discuss AMIC's solutions to the impending shortage of medical isotopes in the United States. Today, the nation imports about 90% of the medical isotopes used in hospitals and clinics. Currently, more than fifteen million nuclear medicine procedures are performed each year in the U.S. According to the official website of Citizens for Medical Isotopes (CMI (Computer-Managed Instruction) Using computers to organize and manage an instructional program for students. It helps create test materials, tracks the results and monitors student progress. ), a national, non-profit organization, current U.S. production resources are not adequate to meet the increasing needs for isotope use in research, diagnosis, and treatment. "AMIC is pleased to share with the UPPI community our progress concerning the issue of medical isotope shortage in the U.S.," said Mr. Katzaroff. "Our recent shipments of short-lived radioisotopes from our Kennewick, Washington production center, and the establishment of key relationships with universities and national laboratories illustrate that we are successfully addressing this serious and growing medical need." About UPPI Established in 1998, UPPI has become a leader in traditional nuclear medicine and in the rapidly growing nuclear and PET pharmacy industries. Representing more than 100 operating sites across the country, UPPI provides its members national strength in buying relationships as well as access to customizable local programs that advance the professionalism of the industry. For more information, please visit http://www.uppi.org/. About Advanced Medical Advanced Medical Isotope Corporation (AMIC) is a medical isotope production company engaged in the production and distribution of medical isotopes and medical isotope in vivo delivery systems for advanced diagnostic and non-surgical therapeutic application. AMIC's goal is to empower physicians, medical researchers, and ultimately patients by providing them with essential medical isotopes that, until now, have not been feasible or economical, in an effort to detect and cure human disease. For more information, please visit our website, http://www.isotopeworld.com. Safe Harbor Statement The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company's control. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion